Pages that link to "Q57606060"
Jump to navigation
Jump to search
The following pages link to A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans (Q57606060):
Displaying 50 items.
- Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. (Q24799062) (← links)
- Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis (Q30248537) (← links)
- Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets (Q33251921) (← links)
- The human obesity gene map: the 1998 update (Q33534349) (← links)
- The human obesity gene map: the 1999 update. (Q33839687) (← links)
- Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms (Q34107495) (← links)
- Rare mutations of peroxisome proliferator-activated receptor gamma: frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa. (Q34114146) (← links)
- PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues (Q34143718) (← links)
- Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen (Q34166268) (← links)
- The human obesity gene map: the 2000 update (Q34227908) (← links)
- Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes (Q34236636) (← links)
- The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity (Q34348367) (← links)
- Impact of genetic variation of PPARgamma in humans (Q34355553) (← links)
- Genome scan for human obesity and linkage to markers in 20q13. (Q34388612) (← links)
- Genetics of leptin and obesity: a HuGE review (Q34428366) (← links)
- The human obesity gene map: the 2001 update (Q34557274) (← links)
- The human obesity gene map: the 2005 update (Q34567973) (← links)
- Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review (Q34568687) (← links)
- Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer (Q34663753) (← links)
- Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer (Q34722267) (← links)
- Genetic susceptibility to ageing-associated diseases (Q34933436) (← links)
- The human obesity gene map: the 2002 update (Q35084465) (← links)
- Peroxisome proliferator-activated receptors and the cardiovascular system (Q35173859) (← links)
- The Genetics of PPARG and the Skeleton (Q35191583) (← links)
- Genetic Polymorphisms in the HTR2C and Peroxisome Proliferator-Activated Receptors Are Not Associated with Metabolic Syndrome in Patients with Schizophrenia Taking Clozapine (Q35238354) (← links)
- Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population (Q35434987) (← links)
- 1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility (Q35683565) (← links)
- The human obesity gene map: the 2003 update (Q35715184) (← links)
- The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis (Q35739803) (← links)
- The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course (Q35788899) (← links)
- Nuclear receptor variants in liver disease (Q35864839) (← links)
- Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome (Q35902614) (← links)
- Peroxisome proliferator-activated receptor gamma: the more the merrier? (Q36018557) (← links)
- PPARgamma in human and mouse physiology (Q36063081) (← links)
- Genetics of Type 2 diabetes. (Q36103109) (← links)
- The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics (Q36326205) (← links)
- Screening of Peroxisome Proliferator-Activated Receptors (PPARs) α, γ and α Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population (Q36351496) (← links)
- PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. (Q36465006) (← links)
- PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease. (Q36528512) (← links)
- Tagging single nucleotide polymorphisms in the PPAR-γ and RXR-α gene and type 2 diabetes risk: a case-control study of a Chinese Han population (Q36681873) (← links)
- Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome (Q37049958) (← links)
- PPARG by dietary fat interaction influences bone mass in mice and humans (Q37194911) (← links)
- PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure (Q37238001) (← links)
- The C1431T polymorphism of peroxisome proliferator activated receptor γ (PPARγ) is associated with low risk of diabetes in a Pakistani cohort (Q37251406) (← links)
- Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease (Q37474084) (← links)
- Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population (Q37498438) (← links)
- Peroxisome proliferator-activated receptor gamma in osteoarthritis (Q37785802) (← links)
- Obesity and eating behaviour in children and adolescents: contribution of common gene polymorphisms (Q38020893) (← links)
- A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity (Q38331543) (← links)
- Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population (Q38513210) (← links)